Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:approvedBy |
gptkb:US_Food_and_Drug_Administration
gptkb:European_Medicines_Agency 2012 |
| gptkbp:ATCCode |
gptkb:J07AH08
|
| gptkbp:contains |
meningococcal polysaccharide conjugated to tetanus toxoid
|
| gptkbp:contraindication |
hypersensitivity to active substances
|
| gptkbp:form |
powder and solvent for solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nimenrix
|
| gptkbp:indication |
adolescents
adults children |
| gptkbp:manufacturer |
gptkb:Pfizer
GlaxoSmithKline |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:protectedBy |
gptkb:Neisseria_meningitidis_serogroup_A
gptkb:Neisseria_meningitidis_serogroup_C gptkb:Neisseria_meningitidis_serogroup_Y Neisseria meningitidis serogroup W |
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue headache injection site pain |
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:usedFor |
prevention of meningococcal disease
|
| gptkbp:bfsParent |
gptkb:meningococcal_conjugate_vaccine
|
| gptkbp:bfsLayer |
7
|